Conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients.
Poschet
J F
JF
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
Boucher
J C
JC
Firoved
A M
AM
Deretic
V
V
D000464:Alginates / Q000378:metabolism; D000818:Animals; D018441:Biofilms / Q000254:growth & development; D001770:Blood Bactericidal Activity; D002237:Carbohydrate Dehydrogenases / Q000235:genetics; D002460:Cell Line; D003550:Cystic Fibrosis / Q000150:complications / Q000382:microbiology*; D004195:Disease Models, Animal; D020723:Glucuronic Acid; D006603:Hexuronic Acids; D006801:Humans; D051379:Mice; D009154:Mutation; D009894:Opportunistic Infections / Q000209:etiology / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000235:genetics / Q000472:pathogenicity* / Q000502:physiology*; D012329:RNA, Bacterial / Q000235:genetics / Q000302:isolation & purification; D012141:Respiratory Tract Infections / Q000209:etiology / Q000382:microbiology
D000464:Alginates; D006603:Hexuronic Acids; D012329:RNA, Bacterial; D020723:Glucuronic Acid; D002237:Carbohydrate Dehydrogenases; C020562:GDPmannose dehydrogenase